Latest Blogs

Subscribe to this column

Linda R. Duska, MD, MPH

Linda R. Duska, MD, MPH, is the editor in chief of ASCO Connection. She is a professor and fellowship director for Gynecologic Oncology at the University of Virginia (UVA). An active member of the Gynecology Oncology Group, she also serves on multiple committees and has authored several investigator-initiated clinical trials at UVA. Her research interests include the evaluation of novel therapeutics and targeted therapy for ovarian and endometrial cancers. Dr. Duska is active in the Foundation for Women's Cancers, where she is the Team Leader for the Surgeons Team for the Race to End Womens Cancers.

Sep 06, 2017
In this issue’s Trainee & Early-Career section, Dr. Melissa Loh shares thoughtful, practical advice for oncology fellows thinking about pursuing a second degree while completing ...
Jul 14, 2017
Everyone has a story about why they became a doctor. But I don’t know anyone who became a doctor because they love paperwork.
Mar 03, 2017
Whether it's your first or twenty-first time attending the ASCO Annual Meeting, you'll find that connections can happen anywhere, not just during sessions or designated networking events.
Aug 12, 2014
A few days ago I had the opportunity to fly in a small passenger (9-person) plane. I’m not a good flyer in general and really small planes make me nervous. I sat directly behind the pilot and decided he must be a good pilot based on his appearance and demeanor (the only data I had). He looked old...
Mar 13, 2014
It’s a hard question, especially for a surgeon. We surgeons like the instant gratification of going in and fixing things. As a surgeon who also gives chemotherapy, managing the end of life is really hard for me in a fundamental way: it’s (in a strange and very personal sense) an admission of...
Jun 10, 2013
Why do patients agree to go on cancer treatment clinical trials? We know that they choose to enroll for a lot of complicated reasons. As a physician and clinical investigator, it makes logical sense to me that patients with cancer want to take advantage of the best and newest treatments, even when...

Pages